Investment Committee Summary
| Rating | HOLD |
| Internal 5-tier | HOLD |
| Classification · conviction | mature cash generator · medium |
| Evidence | 8/8 load-bearing inputs sourced |
| Triangulated fair value | $117 (-1% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $122 (+3% vs spot · 12m PWEV) |
| Next catalyst | 2026-09-18 — Japan (JPY/USD) hedging and investment-portfolio strategy update |
| Primary thesis-break | Total net earned premium growth, year on year < 0.025 (2 consecutive prints) |
Decision detail — rating tables & Research OS strip
Rating: HOLD
Internal 5-tier: HOLD · mature cash generator · analyst conviction: medium
| Metric | Value |
|---|---|
| Current Price | $118 |
| Triangulated Fair Value | $117 (-1% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $122 (+3% vs spot · 12m PWEV) |
| Forward P/E | 14.3x |
| Market Cap | $61B |
| 52-Week Range | $94.92–$129 (high/low reconstructed from the stock's own adjusted-close history — the vendor's recorded range was stale) |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across four weighted anchors — an intrinsic DCF, a scenario-weighted PWEV, a Monte Carlo median (Student-t + regime switching) and a peer P/E re-rate. Anchors that share a market multiple are not independent evidence and are weighted as one view. Figures reconciled to Alpha Vantage 2026-08-24. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Decision Support — Research OS jump to detail ↓
| Research conviction | Exp. return (1y) | Rules stance | Preferred options | Next catalyst |
|---|---|---|---|---|
| 58.9/100 (53rd pct) | +3% 1yr expected | Hold | Covered Call | 24d — Japan (JPY/USD) hedging and investment-portfolio strategy update |
Full breakdown — conviction components, position sizing, probability-return distribution, decision rules, factor & portfolio interaction, options intelligence and the catalyst timeline — in the Decision Support sections below. Model output for research; not individualised advice.
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Recommendation: HOLD
Balanced: triangulated fair value $117 (-1% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Investment Thesis
At $118 (25 August 2026) Aflac trades on 14 times forward earnings, the richest quality premium in its insurer peer group. The market is paying for stability: a return on equity comfortably above the cost of equity, a dividend alongside substantial repurchases, and a supplemental-health franchise with little underwriting volatility. The engine is less generous. The peer earnings-multiple work implies a materially lower value, and a substantial combined weight on the soft-market and reserve-reset states holds the probability-weighted value to $122 and the base-path target to $124, both close to the current price. Triangulated fair value of $117 leaves the shares fairly valued against the anchor set, -1% against spot. The rating is HOLD: the premium is already in the price and the blend does not clear the threshold that would justify paying more. The most damaging risk is a credit-and-reserve reset that values the shares far below the 52-week low.
Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.
The dashboard below is the whole argument on one page: spot ($118) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
Aflac's earnings stability rests on a Japanese block in slow run-off and an investment portfolio that has already produced commercial-real-estate impairments. The structural scenario is a plausible chain, not a tail: yen weakness compresses translated earnings while lapses rise on an ageing policy base; credit losses in transitional real estate and below-investment-grade holdings force realised impairments; and US group products face benefit-ratio normalisation after unusually favourable claims years. In that path revenue contracts, the operating margin falls well below 28%, earnings per share compress sharply, and the multiple de-rates from 14 times into the low double digits as the quality-compounder narrative breaks. The result values the shares below the 52-week low, and the entry multiple offers no cushion against it.
Key Debate
P/E Multiple explains 70% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
What the Market Is Pricing In
At the current price, the market pays 16.8× consensus forward EPS, and a peer median 9.9×.
Variant perception: the house view is above-consensus, and the thesis is primarily growth-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 17.0 | 19.0 | High |
| EPS | 7.0 | 8.3 | Medium |
| Target price | 119.2 | 124.0 | Medium |
Scenario Analysis
The scenario tree spans a structural 'Structural — Underwriting / Reserve / Catastrophe Reset' downside ($54.30) to a 'Bull — Re-Rate' bull case ($215); the probability-weighted blend (PWEV $122) is +3% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — Underwriting / Reserve / Catastrophe Reset | 20% | $54.30 | -54% |
| Soft Market / Investment Loss | 17% | $91.60 | -23% |
| Base — Mid-Cycle Combined Ratio | 35% | $125 | +5% |
| Growth — Hard Market / Pricing + Float Income | 20% | $172 | +46% |
| Bull — Re-Rate | 8% | $215 | +82% |
| Probability-Weighted (PWEV) | — | $122 | +3% |
Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — free cash flow net of SBC is $2.56B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.
Scenario rationale — the driver path behind every target:
- Structural — Underwriting / Reserve / Catastrophe Reset (20%, $54.30). Structural impairment — underwriting / reserve / catastrophe reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
- Soft Market / Investment Loss (17%, $91.60). Cyclical downturn — premium growth + underwriting margin + investment income + reserves weakens for 1–2 years before normalising.
- Base — Mid-Cycle Combined Ratio (35%, $125). Mid-cycle — normalised premium growth + underwriting margin + investment income + reserves; disciplined capital allocation; steady returns.
- Growth — Hard Market / Pricing + Float Income (20%, $172). Upside — hard market + pricing lifts earnings above mid-cycle; the multiple expands modestly.
- Bull — Re-Rate (8%, $215). Upside tail — sustained tight conditions or a structural re-rate on hard market + pricing.
Valuation Triangulation
Four weighted anchors — an intrinsic dcf, a scenario-weighted pwev, a monte carlo median (student-t + regime switching) and a peer p/e re-rate — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat four numbers as four independent votes.
| Method | Basis | Fair Value | vs Spot | Weight in this name's blend |
|---|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $111 | -6% | 18% (declared 15%) |
| Peer P/E re-rate | multiple | $82.00 | -31% | 12% (declared 10%) |
| Peer EV/Revenue re-rate | multiple | $39.55 | -67% | 0% — cross-check only |
| Scenario PWEV | multiple | $122 | +3% | 29% (declared 25%) |
| Justified P/B (ROE-based) | book value × ROE | $127 | +8% | 41% (declared 35%) |
| Triangulated (weighted) | — | $117 | -1% | 100% |
The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts is not computed, so 15% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Book Value, ROE & Capital Returns
For a bank or insurer the cash-flow DCF is the wrong intrinsic anchor — capital is the product. Value is set by return on equity vs cost of equity against book value: the Gordon-justified multiple is P/B = (ROE − g) / (COE − g).
| Metric | Value |
|---|---|
| Book value / share | $58.69 |
| Return on equity (ROE) | 16.5% |
| Cost of equity (assumed) | 9.5% |
| Current P/B | 2.01x |
| Justified P/B (ROE-based) | 2.17x |
| Justified value / share | $127 (+8%) |
ROE of 16.5% comfortably clears the ~10% cost of equity — which is why a premium justified P/B of 2.17x (vs 2.01x current) is warranted. The justified value sits +8% vs spot; that gap, plus the credit / underwriting cycle in the scenarios, is the debate. The Monte Carlo and scenario PWEV carry the earnings (P/E) view; this block carries the book-value view.
Monte Carlo — the outcome distribution
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $111 and 44% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (70% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 9.9x) implies $82.00. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so market sentiment does not set the fair value.
Across all anchors the spread is 79% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| MET | 9.3× | 5% | 10% | segment | 50% |
| PRU | 10.5× | 5% | 5% | segment | 50% |
| PFG | 9.4× | 5% | 15% | segment | 50% |
| GL | 10.4× | 5% | 24% | segment | 50% |
Quality-weighted forward P/E: 9.9× (simple median 9.9×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $94.92–$129, centre $111 (-6% vs spot); spot sits at the 69th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $117 (-1% vs spot · triangulated FV) |
| Downside to bear case (Structural — Underwriting / Reserve / Catastrophe Reset) | $54.30 (-54% vs spot · bear scenario) |
| Reward-to-risk ratio | withheld — the triangulated FV is at or below spot, so there is no reward leg to divide by the risk leg |
| Margin of safety (FV vs spot) | -1% |
| P(price > spot) — Monte Carlo | 44% |
That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; with a leg missing it is withheld rather than computed from a magnitude. Bull case (Bull — Re-Rate): $215.
Company Overview & Business Model
Aflac Incorporated — FINANCIAL SERVICES · INSURANCE - LIFE. Aflac Inc. (American Family Life Assurance Company) is an American insurance company and is the largest provider of supplemental insurance in the United States.
How it makes money.
| Segment | Rev mix | Growth | Op margin | Key driver |
|---|---|---|---|---|
| Insurance (Underwriting + Float) | 100% | +5% | 28% | premium growth + underwriting margin + investment income + reserves |
Edge. Narrow moat. Authored moat rationale withheld pending re-authoring.
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Insurance (Underwriting + Float) | $18.1B | 100% | 5% | 28% | $5.1B | 15.0x | 1% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | premium growth + underwriting margin + investment income + reserves |
| net_debt_or_cash_b | -2.25 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.01 |
| div_yield | 0.0199 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | underwriting / reserve / catastrophe reset |
| upside | hard market + pricing |
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $-62.0B — net cash |
| Net debt / EBITDA | -10.22x |
| Interest coverage (EBIT / interest) | 21.1x |
| Current ratio | 12.39x |
| Lease obligations | $0.1B |
| Cash & ST investments | $70.4B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $2.6B |
| Buybacks / dividends | $3.5B / $1.2B |
| Total shareholder yield | 7.8% |
| Payout as % of FCF | 185.0% |
| Allocation stance | returning more than FCF (balance-sheet funded) |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 14.1% |
| FCF conversion (FCF / net income) | 70.1% |
| FCF yield | 4.2% |
| Capex intensity (capex / revenue) | 0.0% |
| FCF − SBC (diagnostic) | $2.6B |
| Capex split (maint / growth) | 80% / 20% — Capital-light insurer - physical capex is negligible (~1% of revenue) and the AV capex line is a known data gap; spend is systems/technology maintenance with a minority for distribution and digital-enrollment build. The real 'capital' story is investment-portfolio and buyback allocation, not PP&E. |
Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 70% — earnings not cash-backed.
Competitive Moat
Moat sources:
- Dominant supplemental-health share in Japan (worksite/agency distribution moat)
- US supplemental franchise with worksite-enrollment relationships
- Low-volatility underwriting book (supplemental, not P&C catastrophe exposure)
- 16.5% ROE vs ~9.5% cost of equity - a genuine but spread-based, not pricing-power, advantage
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q2): management +0.23 vs analyst floor +0.00 → delta +0.23 (n=26 mgmt / 16 Q&A; 15th pctile across the S&P book, z -1.1).
Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q2 | +0.23 | +0.00 | +0.23 |
| 2026Q1 | +0.33 | +0.00 | +0.33 |
| 2025Q4 | +0.44 | +0.00 | +0.44 |
| 2025Q3 | +0.40 | +0.00 | +0.40 |
News (last 365d, 1269 articles): avg ticker sentiment +0.08 (bullish 16% / bearish 4%)
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $119 (+1% vs spot · street) |
| House target | $124 (+4.1% vs street) |
| Sell-side coverage | 14 analysts (SB 2 / B 1 / H 8 / S 2 / SS 1; net score 0.04) |
| Consensus FY EPS | $7.04; house above (+17.5%) |
| Consensus FY revenue | $17.0B; house above (+11.9%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Catalyst Calendar
- 2026-09-18 (~25d) — Japan (JPY/USD) hedging and investment-portfolio strategy update (authored)
- 2026-11-04 (~72d) — FY2026 results with Japan persistency and US sales-growth update (authored)
- 2027-02-10 (~170d) — Capital-management / buyback and dividend update (FY2027 plan) (authored)
Forecast Track Record
- EPS surprise: beat 38% of the last 8 quarters; average surprise +7.1%.
- Prior-forecast backtest (12 snapshots, 2026-06-27→2026-08-20): directional hit-rate 67%; mean predicted -0.1% vs realised -4.8%. Disconfirming track record is reported, not suppressed.
Catalyst Timeline
6 catalysts in the next 90 days (of 15 tracked). Importance 1–3; confidence 0–1.
| When | Catalyst | Type | Importance | Confidence |
|---|---|---|---|---|
| 2026-09-16 (in 22d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-09-18 (in 24d) | Japan (JPY/USD) hedging and investment-portfolio strategy update | authored | ● | 0.7 |
| 2026-09-18 (in 24d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2026-10-14 (in 50d) | September CPI | macro | ●● | 0.8 |
| 2026-10-28 (in 64d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2026-11-04 (in 71d) | FY2026 results with Japan persistency and US sales-growth update | authored | ● | 0.7 |
| 2026-12-09 (in 106d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-12-18 (in 115d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-01-27 (in 155d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-02-10 (in 169d) | Capital-management / buyback and dividend update (FY2027 plan) | authored | ● | 0.7 |
| 2027-03-17 (in 204d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-03-19 (in 206d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-04-28 (in 246d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-06-09 (in 288d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
_Sources: extended.catalysts, data/catalysts/
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| Japan FSA solvency / capital regime (economic value-based ESR) and JPY-hedging cost regulation | medium (~40%) | medium - Japan is the majority of earnings; capital-regime shifts ~5-8% of FV | 12-24m |
| US supplemental-health / worksite-benefits regulatory and tax treatment changes | low (~20%) | low - stable regulatory backdrop for supplemental products; <3% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — Underwriting / Reserve / Catastrophe Reset | A structural deterioration in the supplemental-health book (adverse claims, reserve strengthening) plus a Japan persistency decline resets earnings power lower; the quality premium unwinds. | Reserve inadequacy surfaces alongside falling Japan persistency, hitting both book value and the multiple. |
| Soft Market / Investment Loss | A soft-pricing insurance market plus investment losses on the float portfolio (credit marks, JPY-hedge costs) compress the ROE below the through-cycle trend. | Falling rates cut float income while FX/hedge costs rise, squeezing the spread from both ends. |
| Base — Mid-Cycle Combined Ratio | A normalized combined ratio with stable Japan persistency and steady float income sustains a mid-teens ROE; per-share value compounds via buybacks. | The ~14x premium to a ~10x peer median compresses even if underwriting is fine - the market simply re-rates the group. |
| Growth — Hard Market / Pricing + Float Income | A hard supplemental-pricing market plus rising rates lift both underwriting margin and float income, expanding the ROE above trend. | Hard-market pricing gains are competed away, and rising rates that help float also mark down the existing bond portfolio. |
| Bull — Re-Rate | A flight-to-quality bid plus accelerated buybacks re-rate Aflac toward a scarcity multiple for low-volatility insurance earnings. | Re-rating an already-premium insurer leaves no cushion if Japan persistency or reserve adequacy disappoints. |
Decision Rules (Machine-Checked)
Stance: Hold — 0 bullish / 1 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).
| Rule | Condition | Observed | Triggered |
|---|---|---|---|
| R1-valuation-stretch | expected return vs fair value < -12 (upside_pct) |
4.95 | no |
| R2-valuation-opportunity | expected return vs fair value > 15 (upside_pct) |
4.95 | no |
| R3-street-revisions | street net rating stance < -0.25 (extended.consensus.street_score) |
0.04 | no |
| R4-earnings-quality | cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) |
70.1 | YES |
| R5-technical-breakdown | price vs 200-day SMA < 0.85 (technicals.sma_200) |
1.04 | no |
| R6-vol-regime-shift | IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) |
0.98 | no |
Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Total net earned premium growth, year on year < 0.025 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Pre-tax adjusted operating margin < 0.26 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Aflac Japan persistency rate, % < 93 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Net investment losses including credit impairments, quarterly $M > 300 (single event). (rationale withheld pending re-authoring — frozen figure or verdict)
- Adjusted return on equity < 0.13 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
Fact / Inference / Speculation
- FACT: Spot $118; 52-week range $94.92–$129; engine rating HOLD; house target $124 (+5%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
- INFERENCE: Triangulated FV $117 (-1% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits above the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Conviction Score
Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.
58.9/100 (confidence band 46.4–71.4), 53rd percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.
| Component | Score (0–100) | Weight | Inputs |
|---|---|---|---|
| business quality | 67 | 15% | extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct |
| financial strength | 92 | 10% | extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage |
| valuation | 55 | 15% | upside_pct |
| growth | 52 | 10% | reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions |
| earnings visibility | 38 | 10% | extended.forecast_accuracy.eps_surprise.beat_rate_pct |
| moat | 56 | 10% | enrichment.moat.rating |
| technical trend (heuristic — no validation record; weight change reserved for AM-060) | 47 | 10% | technicals.rsi, technicals.sma_50, technicals.sma_200 |
| macro tailwinds | — | 10% | industry_context.house |
| risk profile | 61 | 10% | monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median |
Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.
Score history: 61.1 → 61.1 → 58.5 → 60.4 → 60.4 → 58.8 → 58.8 → 58.8.
Probability-Weighted Return Profile
Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.
| Scenario | Probability | Target | Total return | Contribution |
|---|---|---|---|---|
| Structural — Underwriting / Reserve / Catastrophe Reset | 20% | $54.30 | -54.1% | -10.8pp |
| Soft Market / Investment Loss | 17% | $91.60 | -22.5% | -3.8pp |
| Base — Mid-Cycle Combined Ratio | 35% | $125 | +5.5% | +1.9pp |
| Growth — Hard Market / Pricing + Float Income | 20% | $172 | +45.5% | +9.1pp |
| Bull — Re-Rate | 8% | $215 | +82.2% | +6.6pp |
| Aggregate | Value |
|---|---|
| Expected return (gross, 1y) | +3.0% |
| Expected return net of SBC dilution | +3.0% |
| Outcome dispersion (σ, from MC p10–p90) | 36.5% |
| Expected Sharpe (rf 4%) | -0.03 |
| Downside expectation (prob-weighted loss branches) | -14.6% |
The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.
Expected Alpha
Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).
| Component | Value |
|---|---|
| Expected return (gross, 1y) | 3.0% |
| Risk-free rate | 4.01% (1y proxy (3m/2y midpoint; AV lacks a 1y tenor), as of 2026-08-13) |
| Beta (shrunk, 1y vs SPY) | 0.25 (as of 2026-08-24) |
| Equity risk premium | 4.5% |
| Required return | 5.1% |
| Expected alpha | -2.1% |
| Alpha per unit risk (EA/σ) | -0.06 |
A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.
Probability Cross-Checks
Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.
| Cross-check | Ours | Comparator | Reading |
|---|---|---|---|
| Scenario spread vs options market | 40.3% (1σ) | 14.5% implied | our scenarios are far wider than the options market prices |
| Mass above spot: scenarios vs our own MC | 63.0% | 43.7% | the two expressions of our own view agree |
| Realised scenario frequency | 23 dated anchors | — | 23 dated anchors available; realised-vs-prior comparison is now meaningful. |
Authored set: 5 scenarios, probabilities summing to 1.0, mean target $121.71.
Flagged for review: scenario spread vs the options market. A flag marks a disagreement worth understanding — it does not imply either side is wrong.
Factor Exposures
Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.
| Style | Percentile | Theme | Percentile | |
|---|---|---|---|---|
| Growth | 48 | AI | 8 | |
| Value | 83 | Cloud | 13 | |
| Quality | 25 | Semis | 12 | |
| Momentum | 66 | Consumer | 8 | |
| Low-Vol | 84 | Rates | 11 | |
| USD | 93 | |||
| Energy | 79 |
Market interaction: correlation vs SPY +0.26, vs QQQ +0.10 (trailing ~1y daily returns).
Options Intelligence
Preferred structure: Covered Call. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.
- range-bound with rich premium — harvest elevated vol against a holding (a covered call); an iron condor sells both wings if unhedged
- Direction neutral from the overlay conviction/rating (read-only input).
- IV/RV at the 71st percentile of the cross-section → high vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
- Reported alongside and not used to select: this name's own ATM IV sits at the 67th percentile of its own month-end history (decile 7).
- IV term structure is in contango (longer-dated richer, slope +5.9pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.
IV term structure (contango, slope +5.9pp): 32-DTE 19% · 88-DTE 21% · 389-DTE 25%
| Priced structure | Value |
|---|---|
| Legs | Short 126 C |
| Expiry | 2026-09-25 |
| Income yield | 0.0% |
Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.
Alternatives: Iron Condor, Cash-Secured Put. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Position Sizing Framework
| Parameter | Value |
|---|---|
| Initial position | 0.50% NAV |
| Maximum position | 0.83% NAV |
| Risk budget | 1.38% NAV |
| Annualized outcome σ (MC) | 36.5% |
| Indicative holding period | 3–12 months |
| Liquidity | high, ~$248M ADV (adv usd 21 (split-adjusted 21d average, AM-046)), ~0.1 days to exit |
| Rebalancing trigger | position drifts ±25% from target weight, or the decision-rules stance changes |
Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Options Overlay
A defined-risk way to express the HOLD equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.
Market signals — ATM IV 19.0% (moderate regime) · expected move ±4.3% (2026-09-25) · put/call OI 0.62 · ATM Δ 0.55 / Θ -0.04 / ν 0.14. Direction: NEUTRAL (implied return -6.4% to triangulated fair value $110.64).
Covered Call (if held) (Income / neutral) — Short 126 C · 2026-09-25 · premium $0.01 · yield 0.0% · priced from the listed chain (EOD marks)
Converts a near-fair holding into income by agreeing to sell at a higher strike — worth weighing when upside looks limited near fair value and being called away is acceptable. Illustrative — no outcome is implied or guaranteed.
Put Spread (income) (Income / would-own) — Short 109 P / Long 100 P · 2026-10-02 · net $0.49 · net entry $108.51 · yield 0.4% · RoR 6.0% · max loss $8.51 · priced from the listed chain (EOD marks)
Gets paid to wait for a lower entry, with the tail capped: the sold put collects premium while the cheaper long wing below it caps the maximum loss at the spread width — a defined-risk alternative to a naked cash-secured put.
Protective Collar (if held) (Hedge) — Long 105 P / Short 130 C · 2027-02-19 · net $0.77 · floor -11.0% · cap +10.0% · priced from the listed chain (EOD marks)
For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.
Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies +3% vs spot
- Monte Carlo median implies -6% vs spot
- DCF fair value implies +8% vs spot
- Bear case (Structural — Underwriting / Reserve / Catastrophe Reset) downside is -54% vs spot
- Net: the valuation anchor itself sits 0.6% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $18.1B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $19.0B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $7.0396 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.512B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $-61.989B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
Research Provenance
| Field | Value |
|---|---|
| Quantitative engine | mch_stock_engine v2.0 |
| Research OS config | ros-1.19.0 |
| Analysis as-of | 2026-08-25 (prices 2026-08-24) |
| Narrative authorship | claude-opus-5 · Claude Code, supervised, drafted 2026-08-16 |
| Human review | Marinus 2026-08-16 |
| Evidence | 8/8 load-bearing inputs sourced; 13/14 mandated claims cited |
| QA | scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here |
Load-Bearing Assumptions
DCF inputs (WACC, terminal multiple) are not applicable to this name's valuation adapter; triangulation leans 41% on DCF, 29% on PWEV, 18% on the Monte Carlo median, 12% on peer-implied value.
Appendix & audit trail — source log, data provenance, disclosures
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-08-24 | Price, market cap, EV, forward P/E | Alpha Vantage 2026-08-24 |
| MCH engine — trailing 252 adjusted closes | derived | 2026-08-24 | 52-week range (vendor's recorded range was stale and was replaced) | trailing 252 sessions of own close history; config value was stale |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-08-24 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-08-24 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-08-24 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-08-24 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-08-24 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-08-24 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-08-24 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Data Sources
- Prices, fundamentals, options chain, earnings — Alpha Vantage.
- Company filings (10-K / 10-Q) — SEC filings via EDGAR.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- This report is produced by the MCH Advisory quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.